deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT01796821

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)

Sponsor: G&E Herbal Biotechnology Co., LTD

Conditions Condyloma Acuminata Condylomata Acuminata Genital Warts Venereal Warts
Interventions SR-T100 gel with 1.0 % SM SR-T100 gel with 2.3% SM Vehicle gel
Updated 12 times since 2017 Last updated: Feb 3, 2020 Started: Aug 31, 2014 Primary completion: Sep 30, 2018 Completion: Oct 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Condyloma Acuminata and Condylomata Acuminata, this trial is completed. The trial is conducted by G&E Herbal Biotechnology Co., LTD and has accumulated 12 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Jan 2019 · 4 months · monthly snapshotActive Not Recruiting~Jan 2019 – ~Mar 2020 · 14 months · monthly snapshotCompleted~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshotCompleted~Dec 2025 – present · 9 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Dec 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2025 — Dec 2025 [monthly]

    Completed PHASE2

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

▶ Show 7 earlier versions

  1. Mar 2020 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jan 2019 — Mar 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Sep 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE2

  4. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE2

  5. Jun 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • G&E Herbal Biotechnology Co., LTD
Data source: G&E Herbal Biotechnology Co., LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations